{
    "SPADE_N_14403": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14403",
            "Peptide Name": "LS-AMP-F1 (Lys-rich; natural AMPs; Spiders, arachnids, Chelicerata, arthropods, invertebrates, animals, UCLL1)",
            "Source": "the Chinese Wolf Spider,Lycosa sinensis",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "TGLGKIGYLMKKLLSKAKV",
            "Sequence Length": 19,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Synergistic AMPs",
                "Antibiofilm"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2048.58,
            "PI": 10.3,
            "Hydrophobicity": 0.22,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Tan H, Wang J, Song Y, Liu S, Lu Z, Luo H, Tang X.2022",
                    "Reference": "Pharmaceutics. 2022 Nov 21;14(11):2540. doi: 10.3390/pharmaceutics14112540.PubMed",
                    "Title": "Antibacterial Potential Analysis of Novel alpha-Helix Peptides in the Chinese Wolf Spider Lycosa sinensis."
                }
            ],
            "Frequent Amino Acids": "KLG",
            "Absent Amino Acids": "CDEFHNOPQRUW",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 10,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (52.63%) toLC-AMP-F1K: 26%, G: 16%, L: 21%. GRAVY: 0.216; Mol Wt: 2048.591; mol formula: C95H170N24O23S1; mol ex coeff: 1490.Activity:  active against Gram- S. typhimurium CGMCC1.1174 (MIC 12.5 uM), E. coli  CCTCC AB 2012883 and 10 clinical strains (MIC 12.5-50 uM), P. aeruginosa 4 clinical strains (MIC 25->50), A. baumannii 6 clinical strains (MIC 3.1-25 uM), S. dysenteriae CGMCC 1.1869 (MIC 25 uM), P-vulgaris CGMCC 1.1651 (MIC >50 uM), Gram+ E. faecium 2 clinical strains (MIC 12.5 uM), S. albus CGMCC 1.3374 (MIC 6.25 uM), S. aureus  4 clincial strains (MIC 25-100 uM), and S. citreus CCTCC AB 91115 (MIC 6.25 uM). Inhibit the formation of biofilms:bacteria:E. coli.Synergy:antibiotics:   Synergy with Azithromycin, Erythromycin, and Doxycycline against E. coli or S. albus.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26790",
                    "Similarity": 1.0,
                    "Sequence": "TGLGKIGYLMKKLLSKAKV"
                },
                {
                    "SPADE_ID": "SPADE_UN_15755",
                    "Similarity": 1.0,
                    "Sequence": "SKAKVVILSALEYL"
                },
                {
                    "SPADE_ID": "SPADE_N_13863",
                    "Similarity": 0.8,
                    "Sequence": "GIFSLIKGAAKVVAKGLGK"
                }
            ]
        }
    }
}